QEII Cancer Centre

Background

As part of QEII New Generation, the redevelopment of the QEII Health Sciences Centre, services are being moved out of the aging Victoria, Centennial and Dickson buildings on the VG site. Those buildings will eventually come down. Care and services will be delivered at other hospitals or new health care facilities being built or renovated. The QEII Cancer Centre, which is currently located at the VG site, will be moved to the Halifax Infirmary site. Construction of the new centre will allow all cancer care to be offered in one location. It will also enhance the teaching and research mandate.

Services

  • Initial and follow-up visits for:
    • radiation, chemo and surgical oncology
    • ear-nose-throat and gynecological oncology
    • hematology
    • palliative care
    • supportive care (social work, counselling)
  • 48 examination rooms
  • 15 counselling rooms
  • about 60 chemotherapy chairs
  • Clinical trials and research

Benefits:

  • Reducing wait times and improving access to care by providing care/treatment in one location eliminating the need to transfer patients between sites (VG and HI)
  • Improving access to emergency care for cancer patients
  • Supporting the use of telemedicine by implementing state-of-the-art technology
  • Allowing teams to work more closely on patient care, improving collaboration between cancer care and other specialties
  • Creating a modern facility with advanced equipment and technology to help recruit and retain health professionals
  • Improving research, teaching opportunities and clinical trials

Quick facts about the QEII Cancer Centre:

  • Atlantic Canada’s largest cancer centre
  • New centre designed to accommodate about 15,000 new visits (diagnosis) and 52,000 follow-up visits a year
  • 273 cancer treatments a day (includes chemo and radiation therapies, and all IV treatments)
  • Have some of the most advanced radiation machines in the country
  • Currently taking part in more than 80 clinical trials
  • Successful in securing a multi-million-dollar grant for cancer research